Arkolith/Insider Trading/VRPX/Form 4/A

Chipman Christopher Michael

Chief Financial OfficerVirpax Pharmaceuticals, Inc. (VRPX) · full profile →Form 4/A · filed Feb 25, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2022Grant(A)61K—$061K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0000905718-22-000425) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML